Senior insider sale
Sr VP, Quality, GMP Oper. & IT at SUPERNUS PHARMACEUTICALS, INC. — senior position signals high conviction
$985.6K
20K shares
What this filing means
MOTTOLA FRANK plans to sell 20K shares of SUPERNUS PHARMACEUTICALS, INC. valued at approximately $985.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/19/2025ACC: 0001950047-25-010562
Officer· Sr VP, Quality, GMP Oper. & IT
Since Feb 2020
20K
Shares to sell
$985.6K
Approx. market value
20K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
12/19/2025
20KTotal acquired20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/19/2025 | Exercise of Stock Options Cash | 20K | — |
| Total | 20K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
20K
Market value
$985.6K
12/19/2025
Total
Units
20K
Value
$985.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/19/2025 | 20K | $985.6K | NASDAQ | Planned |
| Total | 20K | $985.6K | ||